Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 3Phase 3 1Phase 1 1

Status

Active not recruiting 9Completed 6Terminated 5Withdrawn 4Recruiting 4Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 2Other solid neoplasm 1Dermatologic 1Breast 1

Conditions

Head and Neck Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor, Adult 1Neoplasms 1Melanoma 1Carcinoma, Squamous Cell 1Carcinoma 1Breast Neoplasms 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 196Cisplatin 188Magnetic Resonance Spectroscopy 167Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 117Paclitaxel 112Oxaliplatin 110Biopsy 105venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 69sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Tiragolumab × Clear all
NCT05483400 2025-03-30

TIRACAN

University Medical Center Groningen

Phase 2 Recruiting
97 enrolled
DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma

NCT03708224 2025-01-28

Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

University of California, San Francisco

Phase 2 Recruiting
55 enrolled
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

NCT06003621 2024-11-15

MoST-TAP

Omico

Phase 2 Recruiting
96 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT06342037 2024-09-19

TONIC-3

The Netherlands Cancer Institute

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡